TP53 and rheumatoid arthritis: Collectively, RA FLSs derived EVs can promote ECs angiogenesis via miR-1972 targeted p53/mTOR signaling (Graphical Abstract), targeting on RA FLSs derived EVs or miR-1972 provides a promising strategy for the treatment of patients with RA.